Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Clinical trial NCT00317187 · COMPLETED

Trial details

NCT number: NCT00317187
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Diphtheria Whole Cell Pertussis Tetanus Haemophilus Influenzae Type b

Start date: 2004-06-08
Primary completion: 2005-01-16
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.